A Kansas case in which a doctor is accused of unlawfully prescribing Cephalon (CEPH)'s Actiq painkiller among other drugs, leading to the fatal overdoses of fifty-six patients, sheds some light on ...

It was an awful Monday for Cephalon. One disappointing drug trial caused the company's stock to plunge. When the market closed, the stock was down 36% from its previous close of $62.75 ...

Drug maker Cephalon Inc. sent letters to doctors this week warning them that several deaths have been linked to Fentora, its powerful narcotic to treat acute cancer pain. Fentora and its ...

Valeant's (VRX) hostile takeover bid for Cephalon (CEPH) is certainly living up to the "hostile" part: A slideshow it made for investors basically says, "You suck, Cephalon. Hand over your shares ...

From setting unrealistically high sales quotas to pushing larger prescriptions at higher doses, drug maker Cephalon Inc. engaged in questionable practices to expand sales of Actiq, a powerful ...

The arrangement involved an outside joint venture formed last December with two of Cephalon's institutional investors. The investors put up $50 million in exchange for equity in the venture ...

Teva Pharmaceutical Industries Ltd.’s Cephalon unit and Acusphere Inc. sued Celgene Corp. for patent infringement related to the breast cancer drug Abraxane. The lawsuit claims Celgene’s ...

WEST CHESTER, Pa. (CBS.MW) -- Cephalon swung to a profit in the first quarter, but the biotech firm's shares came under pressure in after-hours action Wednesday as sales of key drugs fell short of ...